top of page

Reproductive & Endocrine Systems

Pheochromocytoma

Core Principle of Pheochromocytoma
🧷 Pheochromocytomas are catecholamine-secreting tumors arising from chromaffin cells in the adrenal medulla, while extra-adrenal paragangliomas arise from sympathetic ganglia.
🧷 These tumors produce excessive epinephrine, norepinephrine, or both, leading to episodic or sustained hypertension and a constellation of hyperadrenergic symptoms.
🧷 The "10% rule" historically described pheochromocytomas: 10% bilateral, 10% extra-adrenal, 10% malignant, 10% familial, 10% in children — though modern data shows higher rates of hereditary cases (up to 40%).
🧷 Board pearl: Pheochromocytoma is a rare but critical "can't miss" diagnosis because undiagnosed tumors can cause hypertensive crisis during surgery, pregnancy, or with certain medications.
Solid White Background
Catecholamine Synthesis and Metabolism Pathway
📍 Chromaffin cells synthesize catecholamines: Tyrosine → DOPA (via tyrosine hydroxylase) → Dopamine → Norepinephrine (via dopamine β-hydroxylase) → Epinephrine (via PNMT).
📍 Pheochromocytomas typically secrete norepinephrine > epinephrine, while normal adrenal medulla secretes mainly epinephrine.
📍 Catecholamines are metabolized to metanephrines (normetanephrine from norepinephrine, metanephrine from epinephrine) via COMT, then to VMA via MAO.
📍 Board pearl: Plasma free metanephrines or 24-hour urine fractionated metanephrines are the most sensitive screening tests because tumors continuously metabolize catecholamines intracellularly regardless of secretion.
Solid White Background
Classic Clinical Presentation: The 5 P's
🔹 Paroxysms of symptoms, Pallor, Palpitations, Perspiration (profuse sweating), and Pressure (hypertension).
🔹 Episodes classically last 15-60 minutes and can be triggered by abdominal pressure, exercise, urination, defecation, anesthesia, or foods high in tyramine.
🔹 Between attacks, patients may be normotensive (especially early in disease) or have sustained hypertension.
🔹 Additional symptoms include headache (90% of symptomatic patients), anxiety, tremor, chest or abdominal pain, and weight loss despite normal appetite.
🔹 Board clue: The triad of episodic headache + sweating + palpitations in a hypertensive patient is highly specific for pheochromocytoma.
Solid White Background
Hypertensive Crisis and Catecholamine Effects
α-receptor stimulation → vasoconstriction → severe hypertension, pallor, cool extremities.
β₁-receptor stimulation → increased heart rate, contractility → palpitations, arrhythmias.
β₂-receptor stimulation → tremor, anxiety, glycogenolysis → hyperglycemia.
Massive catecholamine release can cause catecholamine cardiomyopathy with acute heart failure, pulmonary edema, or takotsubo-like syndrome.
Board pearl: Pheochromocytoma can present with orthostatic hypotension despite catecholamine excess due to hypovolemia from pressure natriuresis and downregulated receptors.
Solid White Background
Hereditary Syndromes and Genetic Associations
MEN2A and MEN2B (RET mutations): pheochromocytomas are bilateral in 50-80% of cases.
Von Hippel-Lindau (VHL mutations): pheochromocytomas + hemangioblastomas + clear cell RCC + pancreatic tumors.
Neurofibromatosis type 1 (NF1 mutations): café-au-lait spots + neurofibromas + pheochromocytomas.
Familial paraganglioma syndromes (SDH mutations): often extra-adrenal, higher malignancy risk.
Board pearl: All patients diagnosed with pheochromocytoma should undergo genetic testing, as 40% have germline mutations even without family history.
Solid White Background
Biochemical Diagnosis: Test Selection and Interpretation
🧠 First-line tests: plasma free metanephrines or 24-hour urine fractionated metanephrines (sensitivity >95%).
🧠 Plasma metanephrines: draw after 30 minutes supine rest; 3-4× upper limit of normal is diagnostic.
🧠 24-hour urine: collect during or immediately after symptomatic episode if possible; correct for creatinine.
🧠 False positives: tricyclic antidepressants, decongestants, antipsychotics, withdrawal from clonidine, severe stress.
🧠 Board distinction: Plasma catecholamines are less reliable due to episodic secretion and short half-life — metanephrines are superior.
Solid White Background
Anatomic Localization and Imaging
After biochemical confirmation, localize tumor with CT or MRI of abdomen/pelvis (initial test).
Pheochromocytomas appear as well-circumscribed adrenal masses with avid contrast enhancement; may show cystic degeneration or hemorrhage.
MRI shows characteristic "lightbulb bright" T2 signal due to high water content.
If CT/MRI negative or metastatic disease suspected → ¹²³I-MIBG scan or ⁶⁸Ga-DOTATATE PET.
Board pearl: Never biopsy an adrenal mass without first excluding pheochromocytoma biochemically — biopsy can trigger hypertensive crisis.
Solid White Background
Paragangliomas: Extra-Adrenal Tumors
📌 Arise from sympathetic ganglia along the paravertebral axis from skull base to pelvis.
📌 Common locations: organ of Zuckerkandl (aortic bifurcation), bladder, mediastinum, carotid body, glomus jugulare.
📌 Bladder paragangliomas present with micturition-induced hypertensive episodes and hematuria.
📌 Head/neck paragangliomas (carotid body, glomus tumors) are usually non-secretory but can cause mass effect.
📌 Board clue: Young patient with hypertensive episodes during urination → consider bladder paraganglioma.
Solid White Background
Preoperative Medical Management
📣 α-blockade must precede β-blockade to prevent unopposed α-stimulation → hypertensive crisis.
📣 Start phenoxybenzamine (irreversible α-blocker) or doxazosin (selective α₁-blocker) 10-14 days before surgery.
📣 Add β-blocker only after adequate α-blockade established (blood pressure controlled, orthostatic symptoms).
📣 Liberal salt and fluid intake to expand plasma volume contracted by chronic vasoconstriction.
📣 Board pearl: Starting β-blocker before α-blocker in pheochromocytoma → paradoxical hypertension from unopposed α-receptor stimulation.
Solid White Background
Surgical Approach and Intraoperative Management
🔸 Laparoscopic adrenalectomy is preferred for tumors <6 cm; open approach for larger or invasive tumors.
🔸 Anesthesia team must be prepared for hemodynamic swings: hypertension during tumor manipulation, hypotension after tumor vessel ligation.
🔸 Short-acting agents used intraoperatively: nitroprusside or nicardipine for hypertension, norepinephrine for hypotension.
🔸 Cortical-sparing adrenalectomy considered for bilateral disease to preserve adrenal function.
🔸 Board distinction: Post-resection hypotension results from sudden catecholamine withdrawal + residual α-blockade + hypovolemia.
Solid White Background
Malignant Pheochromocytoma
🧷 No reliable histologic criteria distinguish benign from malignant — diagnosis requires metastases to non-chromaffin tissue.
🧷 Metastatic sites: bones, liver, lungs, lymph nodes (not direct invasion or lymph nodes within tumor).
🧷 Risk factors for malignancy: large size (>5 cm), extra-adrenal location, SDHB mutations.
🧷 ¹²³I-MIBG therapy for metastatic disease; also chemotherapy (CVD regimen), radiation, or peptide receptor radionuclide therapy.
🧷 Board pearl: A pheochromocytoma is only diagnosed as malignant when metastases are found — cellular atypia alone is insufficient.
Solid White Background
Special Clinical Scenarios
📍 Pregnancy: α-methyldopa is contraindicated (can worsen hypertension); use phenoxybenzamine; timing of surgery depends on gestational age.
📍 Hypertensive crisis: phentolamine IV (short-acting α-blocker), avoid pure β-blockers.
📍 Contrast administration: modern non-ionic contrast is generally safe with α-blockade, though historical teaching warned of crisis.
📍 Incidentaloma workup: all adrenal masses require pheochromocytoma exclusion before intervention.
📍 Board clue: Pregnant woman with paroxysmal hypertension unresponsive to standard therapy → screen for pheochromocytoma.
Solid White Background
Post-Operative Follow-Up and Surveillance
🔹 Measure plasma or urine metanephrines 2-4 weeks post-operatively to confirm complete resection.
🔹 Annual biochemical testing lifelong due to risk of recurrence, contralateral disease, or metastases.
🔹 Genetic syndrome patients need screening for associated tumors and family cascade testing.
🔹 5-year survival >95% for benign disease, 40-70% for malignant disease depending on tumor burden.
🔹 Board pearl: Persistently elevated metanephrines post-operatively suggests residual disease, metastases, or second primary tumor.
Solid White Background
Differential Diagnosis of Episodic Symptoms
Panic disorder: no biochemical abnormalities, responds to anxiolytics/SSRIs.
Hyperthyroidism: sustained symptoms, elevated thyroid hormones, suppressed TSH.
Carcinoid syndrome: flushing + diarrhea, elevated 5-HIAA, right heart involvement.
Mastocytosis: flushing + urticaria, elevated tryptase, triggered by physical stimuli.
Drug effects: cocaine, amphetamines, MAO inhibitor + tyramine, clonidine withdrawal.
Board distinction: Pheochromocytoma causes pallor during attacks (vasoconstriction), while carcinoid causes flushing (vasodilation).
Solid White Background
Catecholamine Cardiomyopathy
Chronic catecholamine excess → myocardial fibrosis, LV hypertrophy, dilated cardiomyopathy.
Acute presentation: takotsubo-like syndrome with apical ballooning, pulmonary edema, cardiogenic shock.
ECG shows LVH, strain pattern, arrhythmias; elevated troponin without coronary disease.
Echo reveals global or segmental dysfunction that may reverse after tumor resection.
Board pearl: Young patient with unexplained cardiomyopathy + hypertension → consider pheochromocytoma as reversible cause.
Solid White Background
Drug Interactions and Perioperative Pitfalls
🧠 Metoclopramide, droperidol → dopamine receptor blockade → catecholamine release → crisis.
🧠 Glucagon stimulation test historically used but abandoned due to risk of massive catecholamine release.
🧠 Succinylcholine → fasciculations → abdominal pressure → tumor stimulation.
🧠 Morphine → histamine release → potential crisis (fentanyl preferred).
🧠 Board clue: Question about drugs to avoid in suspected pheochromocytoma → dopamine antagonists, histamine releasers, or direct tumor pressure.
Solid White Background
Biochemical Patterns and Test Interpretation
Norepinephrine-secreting tumors: hypertension + pallor + ↑ normetanephrine.
Epinephrine-secreting tumors: palpitations + tremor + hyperglycemia + ↑ metanephrine.
Dopamine-secreting tumors: rare, often malignant, may have minimal symptoms, ↑ methoxytyramine.
VMA less sensitive than metanephrines; affected by dietary vanillin (chocolate, coffee, bananas).
Board pearl: Plasma metanephrines drawn sitting/standing or during stress → false positive; must be drawn supine after rest.
Solid White Background
Imaging Pitfalls and Problem-Solving
📌 Adrenal adenomas can coexist with pheochromocytoma → biochemical testing essential.
📌 Bilateral adrenal masses in MEN2 → assume bilateral pheochromocytomas until proven otherwise.
📌 Negative imaging with positive biochemistry → consider paraganglioma, whole body imaging.
📌 ¹²³I-MIBG uptake blocked by tricyclics, labetalol → false negative scan.
📌 Board distinction: CT shows enhancement >10 HU and delayed washout <50% suggests pheochromocytoma over adenoma.
Solid White Background
Board Question Stem Patterns
📣 Episodic headache + sweating + palpitations → pheochromocytoma until proven otherwise.
📣 Hypertensive crisis during surgery/labor/colonoscopy → undiagnosed pheochromocytoma.
📣 Young patient + bilateral adrenal masses → MEN2 syndrome.
📣 Hypertension worsening with β-blocker → consider pheochromocytoma with unopposed α-stimulation.
📣 Post-operative hypoglycemia in adrenalectomy patient → loss of catecholamine-induced gluconeogenesis.
📣 Neurofibromas + hypertension → screen for pheochromocytoma.
📣 Elevated metanephrines + negative adrenal imaging → look for paraganglioma.
Solid White Background
One-Line Recap
🔸 Pheochromocytoma is a catecholamine-secreting tumor presenting with episodic hypertension, headache, sweating, and palpitations, diagnosed by elevated plasma/urine metanephrines, localized by CT/MRI, treated with α-blockade before β-blockade then surgical resection, and associated with genetic syndromes in 40% of cases requiring lifelong surveillance.
Solid White Background
bottom of page